Navigation Links
Prolifiq Announces Software for Life Sciences: Accelerates Sales, Embeds Adherence to Regulatory Compliance, Incorporates Good Promotional Practices
Date:9/14/2009

PHILADELPHIA, Sept. 14 /PRNewswire/ -- Today at the annual RAPS (Regulatory Affairs Professionals Society) conference in booth #607, Prolifiq announced software that allows Life Sciences companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences--designed for medical device, pharmaceutical and biotechnology companies--is used to organize, send and track approved digital content to health care practitioners. Mobile sales representatives can customize and disseminate approved sales materials to prospective customers. An embedded rules engine monitors the communication and helps users engage in Good Promotional Practices (GPP).

Constantly evolving guidelines, regulations and laws from multiple governmental bodies make it increasingly difficult for life sciences companies to provide scientific, promotional and educational materials to health care practitioners. Since practitioners often view companies as a valuable source of information, there is strong market demand for a product that facilitates communication that complies with such standards as the FDA's Good Reprint Guidance.

How Prolifiq for Life Sciences Works

Prolifiq for Life Sciences enables mobile sales representatives to easily send approved, compliant information electronically. Imagine a medical device sales representative and a physician walking through a hospital hallway, or at the scrub sink, and the physician needs product materials immediately. Using a mobile device (including Blackberry, iPhone or Windows Mobile) the representative instantly accesses and distributes information--promotional collateral, brochures, videos, podcasts and links--right then and there. The physician receives the information instantly in his/her email inbox. By responding immediately to provider requests, the sales representative can be responsive and remain compliant. To see how Prolifiq for Life Sciences works, please visit www.Prolifiq.net/lifesciences.

"We are marrying compliance and sales, helping companies integrate compliance directly into their marketing, sales and promotional efforts while creating new efficiencies," says Jeff Gaus, CEO of Prolifiq. "We take the headache out of marketing, sales and compliance, enabling life sciences companies to focus on what they do best: developing the best products and technologies to improve life."

Good Promotional Practices Are Good for Life Sciences

Good Promotional Practices (GPP) is a term Prolifiq uses to refer to the composite set of policies and Standard Operating Procedures that ensure life sciences companies comply with applicable laws, regulations, codes of ethics and accepted industry standards related to promotional efforts.

"When Life Sciences companies can exert systematic rules-based control over their communications with providers, they have taken a significant step toward demonstrating a commitment to compliant promotional practices," said Steven Skwara, a member of the national law firm Epstein Becker Green in the Health Care and Life Sciences and Litigation Practices. "In light of the astronomical expenses that investigations or audits can generate, a life sciences company's investment in a system allowing it to comprehensively control and monitor the dissemination of scientific and promotional materials, represents a good risk management practice and helps form a first line of defense."

About Prolifiq

Prolifiq helps sales professionals use digital content in their communications with customers and prospects. Used in highly regulated environments such as Life Sciences and competitive industries such as Technology, Prolifiq's messaging solutions help sellers match approved content to their selling conversation, wrap it in branded messages and measure the effectiveness of their communications. Customers include: AtriCure, Cisco Systems, GE, The BBC, Associated Press, and Getty Images. For more information, visit www.prolifiq.net

Legal Notice: All rights reserved. Prolifiq is either a trademark or registered trademark and the Prolifiq logo is a trademark of Prolifiq Software, Inc. Product specifications are subject to change without notice.

    Media Contacts:
    Lisa MacKenzie or Kelly Stremel
    MacKenzie Marketing Group
     (503) 225-0725
    lisam@mackenzie-marketing.com
    kellys@mackenzie-marketing.com


'/>"/>
SOURCE Prolifiq
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer
2. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
3. CryoLife Announces First Clinical Use of BioFoam(R)
4. Martek Announces Settlement of Patent Dispute with Capsugel France
5. Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
6. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
7. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
8. Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan
9. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
10. Biovista Inc. Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis
11. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... Village, CA (PRWEB) , ... August 17, 2017 ... ... technology for cancer research and personalized medicine, today announced the launch of a ... Kansas City, Missouri. The study’s goal is to evaluate the potential for early ...
(Date:8/16/2017)... ... 2017 , ... Today, 3Bar Biologics Inc ., the ... funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio ... investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally occurring ...
(Date:8/15/2017)... NC (PRWEB) , ... August 15, 2017 , ... ... 2017, celebrating 10 years of successes helping medical technology companies and inventors develop and ... to a renowned full-service national engineering firm with a portfolio of clients in the ...
(Date:8/15/2017)... , ... August 15, 2017 , ... The Conference ... on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The ... 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our experience ...
Breaking Biology Technology:
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):